News
Covid-19 and Pakistan's raging NCD crisis
Sep 2020: Heartfile’s op-ed “Covid-19 and Pakistan's raging NCD crisis” has also been featured in September issue of NCDA’s NCD Digest. The article highlights the increased vulnerability of people living with NCDs to getting seriously ill after contracting COVID-19 infection and in the light of this statistically observable phenomenon, discusses the response-preparedness and capacity of Pakistan's public health system and identifies gaps and fixing those gaps” View More
NCD s and COVID
In order to Get the message across to a wider audience , our recent op-ed entitled “COVID-19 and Pakistan’s raging NCD crises” (originally published in Dawn News on 09 August 2020) is now available in Urdu. Making it available in Urdu shall enable even more people better understand the increased vulnerability of people living with NCDs to COVID-19. The op-ed has been published in Urdu Daily “Al Akhbar” . It has been printed in two parts. Part 1 of the op-ed was printed on 19th 2020 . The second part (part 2) was printed in the same newspaper on 20th Sept 2020. View More
Second meeting of TFA Advisory Group, Pakistan
22nd September,2020: Subsequent to the February 2020 meeting of the TFA advisory group, a follow up meeting of the core Advisory group was conducted at Heartfile. The advisory group reviewed the progress and deliberated on a future course of actions while taking an account of latest developments in the country in order to align the course of actions with the goals of trans-fat elimination. View More
COVID-19 and Pakistan’s raging NCD crises
2 August 2020: Heartfile and colleagues recently published an op-ed in the Dawn newspaper entitled “COVID-19 and Pakistan’s raging NCD crises”. The op-ed highlights the dangerous interlinkages between NCDs and CoVID-19 and stresses the need to address the NCD crises – the leading cause of death in Pakistan and a source of vulnerability to severe illness from COVID-19. View More
Heartfile publishes Special Supplement on Trans- Fatty Acid (TFA) in Journal of the Pakistan Medical Association (JPMA)
June 2020: Heartfile published a special supplement in the Journal of the Pakistan Medical Association (JPMA) in its May 2020 issue titled Trans-Fatty Acid (TFA) elimination in Pakistan: A Situational Analysis. The supplement provides an overview of TFA sources in Pakistan, introduces the country’s regulatory framework governing food, and suggests steps to eliminate industrially-produced TFA from the Pakistani diet. The development of the report which was launched in July 2019 at a national event and its publishing in the premier medical journal is part of ongoing efforts to highlight the TFA issue and garner support towards the implementation of measures… View More
National Consultation on Development of National Action Plan for TFA Elimination in Pakistan
28th Nov ,2019: Heartfile co-hosted a national consultation workshop with @WHOPakistan & Nutrition wing of MoNHSRC in Islamabad to deliberate on the draft action plan which was prepared based on the discussion & suggestions by experts and policy makers in the light of the TFA studies conducted by WHO and Heartfile disseminated in earlier events. Representatives from all province’s food authorities, technical partners, NGOs and INGOs partake in that important discussion and came to a consensus. View More
Constitution of National TFA Advisory and Advocacy Group, Pakistan
26th Sep , 2019 : In the light of WHO’s calls on governments to use the REPLACE action package to eliminate industrially-produced trans-fatty acids from the food supply, Government of Pakistan’s Ministry of National Health Services, Regulation and Coordination (MoNHSR&C) formed a national TFA advisory and advocacy group based on technical personals from the ministry, provincial food authorities, INGO/NGOs and media, to oversee the activities, processes and formulation of necessary policies & strategies to eliminate TFA in Pakistan. View More
TFA Advocacy Seminar
31st July ,2019: Heartfile co-hosted an advocacy seminar with @WHOPakistan & Nutrition wing of MoNHSRC in Islamabad to sketch the prevalence and sources of TFA in Pakistani diet and outlined a road map for policymakers and civil society to make Pakistan #TransFatFree by 2023. View More
WHO TFA Elimination Framework
The REPLACE action package provides a strategic approach to eliminating industrially-produced trans fat from national food supplies, with the goal of global elimination by 2023. The package comprises an overarching technical document that provides a rationale and framework for this integrated approach to trans fat elimination, along with six modules and additional web resources to facilitate implementation. Read More
Reports
Trans-Fatty Acid (TFA) Elimination in Pakistan: A situational Analysis
This report by Heartfile presents findings which highlight the dangers of TFA consumption and outlines the necessary steps and regulations for its removal in Pakistan. This report can be accessed here
Trans Fat Free by 2023 Report
This report presents case studies of six countries in different regions of the world that have enacted policies to eliminate industrially-produced trans fatty acids/trans fat (TFA) from their food supply. This report can be accessed here
Trans fat free by 2030 - Advocacy for trans fat elimination
Industrially produced trans-fatty acids have no known health benefits, and can be replaced with healthier alternatives. This webinar features different country experiences with proven strategies to reduce and eliminate exposure to artificial TFAs. This Report can be accessed here.
Policy Briefs
Trans-fatty Acid Elimination in Pakistan: A Policy Brief
The policy brief on Trans-fatty Acids (TFA) in Pakistan has been prepared by the World Health Organization (WHO) and Ministry of National Health Services Regulations and Coordination (Nutrition Wing) and by Heartfile. This policy brief outlines the prevalence and sources of Trans-Fatty Acids in Pakistani diet and outlines a roadmap for TFA elimination for policymakers and civil society to consider in Pakistan’s context. This Policy can be accessed here.
Press Coverage
